Effective Ebola vaccine draws closer

ebola virus
Early results of an Ebola vaccine efficacy trial show 100% efficacy in individuals, says the World Health Organization. Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola. The independent body of international experts— the Data and Safety Monitoring Board—that conducted

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous How health literate are your patients?
Next Be MedicineWise at all life stages